Tagrisso Tablets (Osimertinib): Product Details, Strengths and FAQs

Tagrisso Tablets contain osimertinib, a targeted anticancer medicine used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of medicines known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Osimertinib works by targeting specific EGFR mutations that can contribute to cancer cell growth.

Treatment eligibility depends on the cancer stage, previous treatment, and the results of an appropriate EGFR mutation test. Tagrisso is a prescription-only medicine that should be used under the supervision of a qualified oncology specialist.

Patients, hospitals, oncology centres, and authorised pharmaceutical procurement teams searching for Tagrisso Tablets should verify the product's strength, manufacturer, packaging, registration status, and supply requirements before placing an order.

Tagrisso Tablets Strengths Available

Tagrisso Tablets are available in the following strengths:

Tagrisso 40 mg Tablets

Tagrisso 80 mg Tablets

Both strengths contain osimertinib as the active ingredient. The appropriate strength and treatment schedule must be determined by the prescribing oncologist according to the approved product information and the patient's clinical circumstances.

Uses of Tagrisso Tablets

Tagrisso is used for specific indications involving EGFR-mutated non-small cell lung cancer. Depending on the applicable approval, these include certain patients receiving treatment after surgery, patients with locally advanced disease following chemoradiation, and patients with advanced or metastatic disease.

Before treatment, the healthcare team evaluates the tumour's EGFR mutation status and determines whether osimertinib is an appropriate treatment option.

Important Safety Information

Possible side effects include diarrhoea, skin rash, dry skin, nail changes, fatigue, and reduced appetite. Serious adverse effects can include inflammation of the lungs, heart-related complications, changes in heart rhythm, and eye inflammation.

Seek prompt medical attention for new or worsening breathing difficulties, persistent cough, chest discomfort, fainting, or significant eye symptoms. Inform the treating doctor about all medicines being taken, existing medical conditions, and pregnancy-related considerations.

Do not start, stop, or change the dose without medical advice. Store the medicine according to the manufacturer's packaging instructions and keep it out of reach of children.

Buying Tagrisso Tablets Online: Important Considerations

When searching for Tagrisso 40 mg or 80 mg Tablets online, buyers should prioritise legitimate, authorised pharmaceutical suppliers and comply with local prescription and import regulations.

Hospitals, pharmacies, licensed distributors, and eligible institutional buyers should confirm product authenticity, batch details, expiry date, storage requirements, and required shipping documentation before procurement.

For international pharmaceutical enquiries, provide the required strength, destination country, intended order quantity, and relevant purchasing documentation so that availability and applicable export requirements can be assessed.

Frequently Asked Questions (FAQs)

1. What is Tagrisso used for?

Tagrisso contains osimertinib and is used to treat certain forms of EGFR-mutated non-small cell lung cancer, depending on the approved indication and the patient's clinical condition.

2. What strengths of Tagrisso Tablets are available?

Tagrisso Tablets are available in 40 mg and 80 mg strengths.

3. What is the active ingredient in Tagrisso?

The active ingredient is osimertinib, a targeted therapy that inhibits specific forms of the EGFR protein involved in cancer cell growth.

4. Can Tagrisso Tablets be purchased online?

Online purchasing depends on the destination country's laws, prescription requirements, and the supplier's authorisation. Patients should obtain the medicine through legitimate, legally authorised channels and follow their oncologist's advice.

5. What are the common side effects of Tagrisso?

Commonly reported side effects include diarrhoea, rash, dry skin, nail changes, and fatigue. Some adverse effects can be serious and require immediate medical evaluation.

6. Is Tagrisso 40 mg the same as Tagrisso 80 mg?

Both contain osimertinib, but they have different strengths. They are not interchangeable without instructions from the prescribing oncologist.

7. What should buyers verify before ordering Tagrisso Tablets?

Buyers should verify the manufacturer, strength, product authenticity, batch and expiry information, local regulatory requirements, prescription documentation, and permitted import arrangements.

Medical disclaimer: This page provides general product information and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult the current approved product information and a qualified healthcare professional.